5种用药方案治疗非淋菌性尿道(宫颈)炎的最小成本分析  

Cost-minimization Analysis of Five Therapeutic Regimes for Nongonorrhea Urethritis (Cervicitis)

作　　者：张红梅[1] 陈晓明[1] 张洁[1] 

机构地区：[1]重庆市第一人民医院,重庆市400011

出　　处：《中国药房》2008年第14期1048-1049,共2页China Pharmacy

摘　　要：目的:评价5种用药方案治疗非淋菌性尿道(宫颈)炎的经济学效果。方法:将255例非淋菌性尿道(宫颈)炎患者随机分为A、B、C、D、E组,分别给予米诺环素、多西环素、阿奇霉素、克拉霉素、左氧氟沙星治疗,观察各组疗效,并进行最小成本分析。结果:A、B、C、D、E组的总有效率分别为92.16%、87.50%、90.38%、88.00%、83.33%(P>0.05),成本分别为119.00、47.60、163.44、86.24、254.24元。结论:B组方案较佳。OBJECTIVE： To evaluate the pharmacoeconomic effectiveness of five therapeutic regimens for non - gonorrhea urethritis （cervicitis）. METHODS： A total of 255 patients with non- gonorrhea urethritis （cervicitis） were randomly assigned to receive minocyeline （Group A）, doxycycline （Group B）, azithromycin （Group C）, clarithromycin （Group D） or levofloxacin （Group E） . The therapeutic effects were observed and the pharmacoeconomic effectiveness of five therapeutic regimens was analyzed. RESULTS： The total effective rates of A, B, C, D and E groups were 92.16%, 87.50%, 90.38%, 88.00% and 83.33%, respectively （P 〉 0.05）, with costs at 119.00, 47.60, 163.44, 86.24 and 254.24yuan, respect- ively. CONCLUSION： Group B is preferable among the 5 groups.

关 键 词：非淋菌性尿道(宫颈)炎 治疗方案 最小成本分析 

分 类 号：R956[医药卫生—药学] R986